The effect of long-term hyperglycemia and treatment with a selective SGLT2 inhibitor, dapagliflozin, for protection of islet function via mechanisms that could go beyond glucose reduction was investigated. The gene discussed is SLC5A2; the disease is Hyperglycemia.